Another therapeutic treating Severe / Critical patients with mortality as an end point is Aviptadil (RLF-100) by Relief Therapeutics and NeuroRX. Like CYDY it has great anecdotal results and it looks like the P2 trial should finish enrollment within the next two weeks. they have applied for EUA and have also been granted Fast Track Designation by the FDA.